[{"AccountsPayableCurrent_0_Q2_USD":14209000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-12336000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":449000.0,"EarningsPerShareDiluted_1_Q2_USD":-1.03,"EarningsPerShareDiluted_2_Q2_USD":-1.62,"InventoryValuationReserves_0_Q2_USD":7425000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":-12336000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":32704000.0,"ProceedsFromLinesOfCredit_2_Q2_USD":15000000.0,"LongTermDebtCurrent_0_Q2_USD":12329000.0,"RepaymentsOfLinesOfCredit_2_Q2_USD":7500000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":5349000.0,"InterestExpenseDebtExcludingAmortization_1_Q2_USD":2206000.0,"InterestExpenseDebtExcludingAmortization_2_Q2_USD":4099000.0,"AmortizationOfFinancingCosts_1_Q2_USD":180000.0,"AmortizationOfFinancingCosts_2_Q2_USD":362000.0,"InterestCostsCapitalized_2_Q2_USD":100000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":17080000.0,"TreasuryStockValueAcquiredCostMethod_2_Q2_USD":1523000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":205745000.0,"TreasuryStockValueAcquiredCostMethod_1_Q2_USD":1035000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":22381000.0,"DeferredIncomeTaxesAndTaxCredits_2_Q2_USD":-14100000.0,"OtherAssetsNoncurrent_0_Q2_USD":1095000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":449000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":168000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":11967000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":11935000.0,"GoodwillImpairmentLoss_2_Q2_USD":0.0,"GoodwillImpairmentLoss_1_Q2_USD":0.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":58130000.0,"DepreciationDepletionAndAmortization_1_Q2_USD":11198000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-14696000.0,"IncomeLossFromContinuingOperations_1_Q2_USD":-12336000.0,"IncomeLossFromContinuingOperations_2_Q2_USD":-19347000.0,"IncreaseDecreaseInIncomeTaxes_2_Q2_USD":9362000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-2360000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-9178000.0,"InterestExpenseDebt_1_Q2_USD":2362000.0,"InterestExpenseDebt_2_Q2_USD":4412000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":53488000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-28525000.0,"LongTermDebtNoncurrent_0_Q2_USD":177879000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":-2356000.0,"AccruedRoyaltiesCurrent_0_Q2_USD":6004000.0,"OperatingLeaseCost_2_Q2_USD":109000.0,"OperatingLeaseLiability_0_Q2_USD":483000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":201000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":282000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q2_USD":-2360000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2_Q2_USD":-9178000.0,"RepaymentsOfOtherLongTermDebt_2_Q2_USD":3279000.0,"ResearchAndDevelopmentInProcess_2_Q2_USD":3753000.0,"OperatingLeaseCost_1_Q2_USD":57000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":5002000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":98244000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":48470000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_2_Q2_USD":0.0,"TreasuryStockCommonShares_0_Q2_shares":57891.0,"TreasuryStockCommonValue_0_Q2_USD":2246000.0,"UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_2_Q2_USD":-19347000.0,"UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_2_Q2_USD":-19347000.0,"ValuationAllowancesAndReservesBalance_0_Q2_USD":72469000.0,"RetailRelatedInventoryPackagingAndOtherSupplies_0_Q2_USD":3038000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":-4388000.0,"NumberOfReportableSegments_2_Q2_segment":1.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":117000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":8160000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5736000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":705000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":-34657000.0,"ContractWithCustomerAssetNet_0_Q2_USD":100000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":125000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_2_Q2_USD":5700000.0,"CumulativeEffectOnRetainedEarningsNetOfTax1_2_Q2_USD":-8000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":30000.0,"DeferredRevenueRevenueRecognized1_2_Q2_USD":300000.0,"InterestRateDerivativeLiabilitiesAtFairValue_0_Q2_USD":16797000.0,"LeaseCost_1_Q2_USD":71000.0,"LeaseCost_2_Q2_USD":138000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":513000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":31000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":61000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":132000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":172000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":19593000.0,"VariableLeaseCost_1_Q2_USD":14000.0,"InterestCostsCapitalizedAdjustment_2_Q2_USD":49000.0,"ImpairmentOfIntangibleAssetsFinitelived_1_Q2_USD":0.0,"InventoryNet_0_Q2_USD":52563000.0,"Liabilities_0_Q2_USD":274047000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":465391000.0,"LiabilitiesCurrent_0_Q2_USD":79088000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":3147000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-60394000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":22590000.0,"NetIncomeLoss_1_Q2_USD":-12336000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":1033000.0,"NetIncomeLoss_2_Q2_USD":-19347000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":39937000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1771000.0,"StockholdersEquity_0_Q2_USD":191344000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":11967000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":11935000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":3066000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":146904000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":2264000.0,"InterestPaidNet_2_Q2_USD":3541000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":665000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-1443000.0,"AccountsReceivableNetCurrent_0_Q2_USD":73162000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":8286000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-14049000.0,"AdditionalPaidInCapital_0_Q2_USD":209409000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":1000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":1400000.0,"Assets_0_Q2_USD":465391000.0,"AssetsCurrent_0_Q2_USD":156544000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-4296000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":27702000.0,"CostOfRevenue_1_Q2_USD":20695000.0,"CostOfRevenue_2_Q2_USD":42499000.0,"CostsAndExpenses_1_Q2_USD":59777000.0,"CostsAndExpenses_2_Q2_USD":117393000.0,"Depreciation_1_Q2_USD":1200000.0,"Depreciation_2_Q2_USD":2300000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-13779000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-23643000.0,"CommonStockValue_0_Q2_USD":1000.0,"InterestCostsCapitalizedAdjustment_1_Q2_USD":24000.0,"OperatingIncomeLoss_1_Q2_USD":-11307000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"InventoryWorkInProcess_0_Q2_USD":733000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":55023000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":352649000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":205745000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-116000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-106000.0,"PrepaidExpenseCurrent_0_Q2_USD":3117000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":161000.0,"InventoryRawMaterials_0_Q2_USD":37703000.0,"DeferredTaxAssetsValuationAllowance_0_Q2_USD":400000.0,"EarningsPerShareBasic_2_Q2_USD":-1.62,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q2_USD":47948000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q2_USD":31093000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":34070000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":34818000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":38223000.0,"Goodwill_0_Q2_USD":3580000.0,"ImpairmentOfIntangibleAssetsFinitelived_2_Q2_USD":0.0,"EarningsPerShareBasic_1_Q2_USD":-1.03,"OperatingIncomeLoss_2_Q2_USD":-19149000.0,"InventoryGross_0_Q2_USD":59988000.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":-878000.0,"PreferredStockSharesAuthorized_0_Q2_shares":1666667.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":0.0,"ResearchAndDevelopmentExpense_1_Q2_USD":3035000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":9379000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":21213000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":34896000.0,"InventoryFinishedGoods_0_Q2_USD":18514000.0,"ShareBasedCompensation_2_Q2_USD":8160000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":11967000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":15086000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":10000000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":20100000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.105,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.182,"IncomeTaxesPaid_2_Q2_USD":523000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-4055000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":11935000.0,"VariableLeaseCost_2_Q2_USD":29000.0,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]